AVITA Medical Presents First Clinical Data of RECELL GO in the UK
AVITA Medical announced the presentation of new clinical data highlighting the first documented use of RECELL GO in the United Kingdom at the 2026 British Burn Association (BBA) Annual Meeting in Nottingham, U.K. The presentation, titled "First U.K. Clinical Experience of RECELL GO, an Automated Autologous Cell Harvesting Device, in Burn Surgery: A Case Series," reports outcomes from 17 patients treated at Stoke Mandeville Hospital, one of the U.K.'s leading specialist burn units. Investigators evaluated the use of RECELL GO, AVITA Medical's next-generation automated system for preparing RECELL Spray-On Skin Cells, across a range of burn and reconstructive procedures. In the U.K. case series, all patients successfully received RECELL Spray-On Skin Cells prepared using RECELL GO, either alone or in conjunction with meshed split-thickness skin grafts. Investigators reported uncomplicated donor-site healing, complete graft take, and successful patient discharge without complications. The authors also noted workflow benefits, including reduced procedural variability, improved consistency of cell preparation, and greater operating room efficiency.
